Moneycontrol PRO
you are here: HomeNewsZydus cadila
zydus cadila
Jump to
192 Results Found
  • Zydus Cadila COVID-19 vaccine: Decision on emergency use approval likely this week Jul 12, 2021 08:41 AM IST

    Zydus Cadila COVID-19 vaccine: Decision on emergency use approval likely this week

    If approved, Zydus Cadila's jab will be the fifth COVID-19 vaccine to get approved in India after Covishield, Covaxin, Sputnik V and Moderna.

  • Zydus Cadila’s Sharvil Patel:  We will manufacture one crore doses per month initially Jul 10, 2021 01:21 PM IST

    Zydus Cadila’s Sharvil Patel: We will manufacture one crore doses per month initially

    Managing Director of Zydus Group Sharvil Patel says the company has invested Rs. 400-500 crore for the development of ZyCoV-D, the world’s first plasmid DNA vaccine for human use.

  • Zydus Cadila gets USFDA nod to market generic HIV infection treatment tablets Jul 02, 2021 02:49 PM IST

    Zydus Cadila gets USFDA nod to market generic HIV infection treatment tablets

    The company has received final approval from the United States Food and Drug Administration (USFDA) to market Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 100 mg/150 mg, 133 mg/200 mg and 167 mg/250 mg, Zydus Cadila said in a statement.

  • Needle-free, three doses—here’s all you need to know about Zydus Cadila’s COVID jab Jul 02, 2021 02:41 PM IST

    Needle-free, three doses—here’s all you need to know about Zydus Cadila’s COVID jab

    Zydus Cadila conducted trials of ZyCoV-D at 50 sites spread across the country, making it the largest such trial in the country. It is also the first COVID vaccine in India to be tested among the 12-18 age group

  • Zydus Cadila's COVID-19 vaccine will be available for 12-18 age group soon, Centre tells SC Jun 27, 2021 09:24 AM IST

    Zydus Cadila's COVID-19 vaccine will be available for 12-18 age group soon, Centre tells SC

    The Centre said that a total of 51.6 crore COVID-19 vaccine doses would be made available by July 31 of which 35.6 crore have already been provided.

  • Zydus Cadila gets USFDA approval for generic cancer drug Jun 25, 2021 12:33 PM IST

    Zydus Cadila gets USFDA approval for generic cancer drug

    The Ahmedabad-based drug maker has received approval from the US Food and Drug Administration (USFDA) for the injection in the strengths of 100mg/vial, 500 mg/vial, and 1000 mg/vial, single-dose vials, Zydus Cadila said in a statement.

  • Zydus Cadila gets USFDA tentative nod for epilepsy treatment drug Jun 14, 2021 12:00 PM IST

    Zydus Cadila gets USFDA tentative nod for epilepsy treatment drug

    Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, Cadila Healthcare said in a regulatory filing.

  • Zydus gets SEC nod to conduct clinical trial of COVID-19 antibody cocktail Jun 04, 2021 08:50 AM IST

    Zydus gets SEC nod to conduct clinical trial of COVID-19 antibody cocktail

    The antibody cocktail therapy is most suited for high-risk COVID-19 patients within the first 10 days of onset of symptoms and meet any of the listed criteria such as age being 65 years or above.

  • Zydus Cadila launches breast cancer treatment drug Ujvira May 24, 2021 11:13 AM IST

    Zydus Cadila launches breast cancer treatment drug Ujvira

    The company has launched Trastuzumab Emtansine, the first antibody drug conjugate (ADC) biosimilar and a highly effective drug for treating both early and advanced HER2 positive breast cancer, under the brand name Ujvira, Zydus Cadila said in a statement.

  • Zydus pegs price of COVID-19 drug Virafin at Rs 11,995, says it can cut oxygen dependency in patients May 11, 2021 02:42 PM IST

    Zydus pegs price of COVID-19 drug Virafin at Rs 11,995, says it can cut oxygen dependency in patients

    The reduction in usage of supplemental oxygen, as claimed by Zydus, could come as a relief to states that are struggling in the COVID-19 fight due to the stressed supply of medical oxygen.

  • Zydus Cadila likely to seek approval for its COVID-19 vaccine this month May 05, 2021 09:38 AM IST

    Zydus Cadila likely to seek approval for its COVID-19 vaccine this month

    Zydus Cadila is planning to produce 10 million doses per month of its COVID-19 vaccine, to begin with, and subsequently raise it to 20 million doses.

  • Zydus gets DCGI nod for emergency use of 'Virafin' in treating moderate COVID-19 cases Apr 23, 2021 03:17 PM IST

    Zydus gets DCGI nod for emergency use of 'Virafin' in treating moderate COVID-19 cases

    The company has claimed that 91.15 percent of COVID-19 patients treated with Virafin were RT-PCR negative by day 7.

  • Zydus Cadila gets USFDA nod to market anti-arrhythmic drug Apr 23, 2021 11:11 AM IST

    Zydus Cadila gets USFDA nod to market anti-arrhythmic drug

    Propafenone is known as an anti-arrhythmic drug. It works by blocking the activity of certain electrical signals in the heart that can cause an irregular heartbeat.

  • Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drug Apr 08, 2021 01:21 PM IST

    Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drug

    Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.

  • Zydus Cadila reduces price of generic COVID-19 drug to Rs 899 per vial Mar 24, 2021 04:47 PM IST

    Zydus Cadila reduces price of generic COVID-19 drug to Rs 899 per vial

    Remdesivir is a critical drug in the treatment of COVID-19. "This move to further revise the prices will go a long way in helping patients during these critical times," Zydus Cadila said in a statement.

  • Cadila Healthcare’s animal health business: Multiples PE-CPPIB alliance emerges frontrunner Mar 08, 2021 05:36 PM IST

    Cadila Healthcare’s animal health business: Multiples PE-CPPIB alliance emerges frontrunner

    Founded in 2009, Multiples PE is headed by CEO & Founder Renuka Ramnath, the former MD & CEO of ICICI Ventures. In the pharma & healthcare segment, Multiples PE has invested in firms like Natco Pharma, Encube Ethicals and Bengaluru-based Vikram Hospitals.

  • Zydus Cadila gets USFDA nod for antidepressant drug Feb 25, 2021 01:22 PM IST

    Zydus Cadila gets USFDA nod for antidepressant drug

    Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride capsules USP, in strengths of 10 mg, 25 mg, 50 mg and 75 mg, Cadila Healthcare said in a regulatory filing.

  • USFDA grants orphan drug designation to Zydus Cadila's Saroglitazar Mg Jan 28, 2021 11:25 AM IST

    USFDA grants orphan drug designation to Zydus Cadila's Saroglitazar Mg

    Zydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, including tax credits for qualified clinical testing, prescription drug user fee exemptions and seven-year marketing exclusivity upon USFDA approval.

  • Status check on COVID-19 vaccines in pipeline for India over next six months Jan 20, 2021 08:44 PM IST

    Status check on COVID-19 vaccines in pipeline for India over next six months

    In the initial phase, India will inoculate about one crore healthcare workers. This will be followed by two crore frontline workers, police, armed forces, municipal workers, revenue staff and others. In the third phase, 27 crore people above 50 years of age and those with co-morbidities.

  • Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine Jan 03, 2021 05:46 PM IST

    Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine

    The company will now be initiating Phase III clinical trial in around 30,000 volunteers, Zydus Cadila said in a statement.

  • Zydus Cadila plans to test its COVID-19 vaccine on 30,000 volunteers in late stage trial Dec 24, 2020 10:15 PM IST

    Zydus Cadila plans to test its COVID-19 vaccine on 30,000 volunteers in late stage trial

    Cadila Healthcare said its vaccine was found to be well tolerated and immunogenic in the Phase I/II clinical trials.

  • Zydus Cadila gets USFDA Fast Track Designation for Saroglitazar Dec 09, 2020 03:32 PM IST

    Zydus Cadila gets USFDA Fast Track Designation for Saroglitazar

    Fast Track is a process of the USFDA to expedite the review of drugs to treat serious conditions and fill an unmet medical need. A drug that receives Fast Track Designation is eligible for accelerated approval and priority review, if the relevant criteria are met, Zydus Cadila said in a statement.

  • Pfizer COVID vaccine ready for use in UK: What is India's plan on vaccination? Dec 02, 2020 05:45 PM IST

    Pfizer COVID vaccine ready for use in UK: What is India's plan on vaccination?

    India's COVID-19 vaccination drive will be among the largest in the world and is likely to happen in phases.

  • PM Modi's presence to motivate company in quest to bridge unmet healthcare needs: Zydus Cadila Nov 28, 2020 03:38 PM IST

    PM Modi's presence to motivate company in quest to bridge unmet healthcare needs: Zydus Cadila

    PM Modi visited Zydus Cadila’s manufacturing facility near Ahmedabad, as he began his three-city visit to review ongoing coronavirus vaccine development work.

  • PM Modi to visit Zydus Cadila's COVID-19 vaccine development centre in Gujarat on November 28 Nov 27, 2020 03:06 PM IST

    PM Modi to visit Zydus Cadila's COVID-19 vaccine development centre in Gujarat on November 28

    An official said that the prime minister is likely to arrive at the plant around 9.30 am.

Sections
ISO 27001 - BSI Assurance Mark